SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

BofA Securities Cuts Candel Therapeutics Price Target to $15 From $18

BofA Securities adjusted its price target on Candel Therapeutics to $15 from $18.

CADL

Related stories